… carcinoma (10, 11, 12) or aggressive pituitary adenomas … temozolomide treatment and
its relationship to MGMT expression in a series of six patients with aggressive pituitary tumors. …

… regarding temozolomide in the treatment of pituitary tumors. … A significant number of
patients with these adenomas have … Patients with aggressive pituitary adenomas present with …

… of pituitary adenoma have been treated with temozolomide (7-16,1820,22-26,28,29). Patient
ages … Aside from one tumor that was incidentally discovered in a patient with concomitant …

… with temozolomide … temozolomide. Objectives: The objective of the study was to describe
the antitumoral efficacy and toxicity of temozolomide in patients with aggressive pituitary tumors …

… with progressive pituitary adenoma or carcinoma. We report a survey study of Italian
patients treated with Temozolomide because of aggressive pituitary adenoma or carcinoma …

… Pituitary adenomas (PAs) are common intracranial tumors … small number of patients with
aggressive pituitary tumors (APTs) … , ~0.2% of pituitary adenomas are characterized as pituitary …

… with low MGMT expression responded to temozolomide treatment, whereas that with high
… of using temozolomide to treat aggressive pituitary adenomas. However, our second patient …

… Only few retrospective studies have reported an efficacy rate of temozolomide (TMZ) in
pituitary tumors (PT), all around 50%. However, the long-term survival of treated patients is rarely …

… reported in a limited number of cases with tumor volume reduction and control of the disease
… the use of temozolomide in six patients with different variants of aggressive pituitary tumors. …

… to initiation of TMZ treatment in patients with pituitary tumors and to assess clinical outcome.
The … of pituitary tumors (SP, JH, UE) and presented to the members of the Pituitary Working …